Vanda Gains FDA Rare Pediatric Designation for VCA-894A
WASHINGTON, July 7, 2026 Vanda Pharmaceuticals Inc. has announced that the U.S. Food and Drug Administration (FDA) has granted...
AI drug discovery artificial intelligence Autoimmune Disease biologics Biomarkers biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery EMA FDA fda approval FDA clearance Gene Therapy Healthcare Innovation healthcare technology immunology Immunotherapy Medical Devices MedTech Monoclonal Antibody Neurodegenerative Disease Neurology Oncology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine targeted therapy
WASHINGTON, July 7, 2026 Vanda Pharmaceuticals Inc. has announced that the U.S. Food and Drug Administration (FDA) has granted...
SAN LEANDRO, Calif., July 7, 2026 WAVES Veterinary Emergency & Specialty Hospital has officially opened its doors in San...
BOSTON, May 12, 2026 Servier has announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy...
OVERLAND PARK, Kan., and BOULDER, Colo., May 12, 2026 Hill’s Pet Nutrition and Bond Pet Foods have announced a...
PENSACOLA, Fla., Feb. 12, 2026 — The U.S. Food and Drug Administration has granted full approval to KBroVet (potassium...
RAHWAY, N.J., September 26, 2025 – Merck Animal Health, known as MSD Animal Health outside the U.S. and Canada...
San Diego, CA – September 23, 2025 — Gallant, an animal-health biotechnology company specializing in regenerative medicine, announced that...
